Management of Anticoagulation after Lower Gastrointestinal Bleeding

Introduction to Restarting Anticoagulation

The American Gastroenterological Association recommends restarting Xarelto (rivaroxaban) a maximum of 7 days after lower gastrointestinal bleeding has stopped, assuming hemostasis has been achieved, to balance thrombotic and rebleeding risks 1
High thrombotic risk patients may consider earlier resumption of Xarelto (but not before day 3), while low thrombotic risk patients should adhere to the 7-day waiting period 1

Patients with high thrombotic risk, such as those with a prosthetic metal heart valve in mitral position, atrial fibrillation with prosthetic heart valve or mitral stenosis, or recent venous thromboembolism (<3 months), may require earlier restart of anticoagulation 2
Patients with low thrombotic risk, such as those with atrial fibrillation without valvular disease or venous thromboembolism >3 months ago, should follow the standard 7-day waiting period 1

For patients with high thrombotic risk who cannot tolerate 7 days without anticoagulation, consider low molecular weight heparin (LMWH) bridging therapy starting 48 hours after hemostasis has been achieved, as recommended by the American College of Cardiology 1
Unfractionated heparin may be preferred over LMWH in some cases due to its shorter half-life (1-2 hours), allowing for more rapid reversal if rebleeding occurs, according to the American Heart Association 2

Close follow-up within 1-2 weeks after restarting Xarelto is recommended to monitor for signs of recurrent bleeding, as suggested by the American Gastroenterological Association 1
Patients should be educated about warning signs of bleeding that require immediate medical attention, such as severe abdominal pain or vomiting blood, as advised by the National Institute of Diabetes and Digestive and Kidney Diseases 1

If a patient had life-threatening bleeding, consider switching to warfarin instead of restarting Xarelto, as warfarin has more effective and rapid reversal options, according to the American College of Cardiology 1
If bleeding was related to a correctable cause (e.g., specific lesion that has been treated), consider earlier reinitiation of anticoagulation if the risk of thrombosis is significant, as recommended by the American Heart Association 1

Restarting anticoagulation too early (before day 3) increases rebleeding risk significantly, while delaying anticoagulation beyond 7 days unnecessarily increases thrombotic risk, as reported by the American Gastroenterological Association 1
Failing to coordinate with the prescribing physician who initiated anticoagulation therapy or not addressing modifiable risk factors for GI bleeding before restarting anticoagulation can also increase risks, according to the National Institute of Diabetes and Digestive and Kidney Diseases 2